Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Regulatory News (OBD)

Share Price Information for Oxford Biodyn (OBD)

Share Price is delayed by 15 minutes
Get Live Data
0.19    0.00 (0.00%)
Bid:
0.18
Ask:
0.20
Spread: 0.02 (11.111%)
Market Cap: £8.15m
OBD Live PriceLast checked at - London Stock Exchange

Intraday Oxford Biodyn Share Chart

Holding(s) in Company

5 Feb 2025 14:11

RNS Number : 0570W
Oxford BioDynamics PLC
05 February 2025
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Oxford Biodynamics plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

X

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Unicorn Asset Management Limited

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

Unicorn AIM VCT plc

City and country of registered office (if applicable)

Teignmouth, Devon, United Kingdom

5. Date on which the threshold was crossed or reachedvi:

03 February 2025

6. Date on which issuer notified (DD/MM/YYYY):

05 February 2025

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

23.00%

23.00%

145,131,526

Position of previous notification (if

applicable)

7.94%

7.94%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary shares GB00BD5H8572

145,131,526

23.00%

SUBTOTAL 8. A

145,131,526

23.00%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting, please identify:

Name of the proxy holder

See Section 4

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

Figures are based on total voting rights of 630,919,226

 

Place of completion

Unicorn Asset Management Limited, Preachers Court, Charterhouse, Charterhouse Square, London, EC1M 6AU

Date of completion

05 February 2025

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEALASEENSEFA
Date   Source Headline
15th Apr 20267:00 amRNSBoard Appointment
30th Mar 20264:07 pmRNSHolding(s) in Company
20th Mar 202612:03 pmRNSHolding(s) in Company
3rd Mar 20269:30 amRNS-ROBD to present at PMWC 2026
17th Feb 20267:00 amRNSChange of Nominated Adviser
27th Jan 202612:52 pmRNSHolding(s) in Company
26th Jan 202612:10 pmRNSResult of AGM
26th Jan 20267:00 amRNSBoard Change
22nd Dec 202511:00 amRNSPublication of 2025 Annual Report
22nd Dec 202511:00 amRNSPublication of 2025 Annual Report
16th Dec 20257:00 amRNSPreliminary Results and Notice of AGM
9th Dec 202512:40 pmRNSNotice of Results
3rd Dec 20257:00 amRNSStatement re share price, update on EpiSwitch PSE
25th Nov 20252:05 pmRNSHolding(s) in Company
12th Nov 20257:00 amRNSHolding(s) in Company
11th Nov 20252:12 pmRNSHolding(s) in Company
11th Nov 20252:11 pmRNSHolding(s) in Company
11th Nov 20252:10 pmRNSHolding(s) in Company
10th Nov 20257:00 amRNSPDMR Dealing / Grant of Share Options
7th Nov 202511:32 amRNSResult of General Meeting/PDMR Dealings
22nd Oct 20257:00 amRNSFundraising, Posting of Circular & Notice of GM
14th Oct 20257:00 amRNS-ROBD in New Report on NHS Prostate Cancer Screening
8th Oct 20257:00 amRNSOBD and UEA develop test for Chronic Fatigue
10th Sep 20257:00 amRNSHolding(s) in Company
4th Sep 202510:00 amRNS-RStudy confirms clinical utility of EpiSwitch CiRT
13th Aug 20257:00 amRNSCollaboration with Google Cloud
18th Jul 20253:11 pmRNSHolding(s) in Company
17th Jul 20257:01 amRNS-RGenomeWeb to host joint Agilent/OBD presentation
17th Jul 20257:00 amRNSHolding(s) in Company
15th Jul 20255:20 pmRNSHolding(s) in Company
15th Jul 20257:00 amRNS-RPfizer study on EpiSwitch biomarkers
1st Jul 20253:00 pmRNSHolding(s) in Company
30th Jun 20257:00 amRNSInterim Results
27th Jun 20251:30 pmRNSHolding(s) in Company
9th May 20257:00 amRNS-ROBD’s Oxford Lab accredited by UKAS
10th Apr 20254:10 pmRNSDirector/PDMR Shareholding
2nd Apr 20257:00 amRNSPDMR Dealing
28th Mar 202510:35 amRNSResult of AGM
17th Mar 20257:00 amRNSBoard Changes
14th Mar 20255:25 pmRNSHolding(s) in Company
13th Mar 20257:00 amRNS-RExpansion of OBD/Bupa UK insurance partnership
5th Mar 20254:00 pmRNSPublication of 2024 Annual Report
3rd Mar 20257:00 amRNSPDMR Dealing / Grant of Share Options
28th Feb 20257:00 amRNSPreliminary Results and Notice of AGM
21st Feb 202510:00 amRNSNotice of Preliminary Results
17th Feb 20251:07 pmRNSHolding(s) in Company
12th Feb 20254:48 pmRNSHolding(s) in Company
12th Feb 20257:00 amRNS-ROBD partners with Regina Maria in Romania
10th Feb 202512:09 pmRNSHolding(s) in Company
6th Feb 20251:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.